Results 31 to 40 of about 8,385 (178)

Risk of sequelae after invasive meningococcal disease [PDF]

BMC Infectious Diseases, 2022
Abstract Background Invasive meningococcal disease (IMD) is a rare but severe bacterial infection, of which a high proportion of survivors are affected by sequelae. In Denmark, IMD is a notifiable disease and data collection on sequelae information has been automated, enabling studies of sequelae due to IMD diagnosed ...
Sidsel Skou Voss, Jens Nielsen, Palle Valentiner-Branth   +2 more
openaire   +3 more sources

Invasive meningococcal disease in children in Jerusalem

Epidemiology and Infection, 2007
SUMMARYNeisseria meningitidisis an important cause of childhood meningitis and septicaemia. Between 1999 and 2005, 133 invasive meningococcal disease (IMD) cases occurred in Jerusalem, 112 (84·2%) of them in children aged 0–14 years. The annual incidence rate in Jerusalem was higher than the national average (2·45±0·6vs.
C, Stein-Zamir, N, Abramson, G, Zentner, H, Shoob, L, Valinsky, C, Block   +5 more
openaire   +3 more sources

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence [version 1; peer review: 2 approved]

Wellcome Open Research, 2019
Carriage of Neisseria meningitidis, the meningococcus, is a prerequisite for invasive meningococcal disease (IMD), a potentially devastating infection that disproportionately afflicts infants and children.
Holly B. Bratcher, Charlene M. C. Rodrigues, Adam Finn, Mandy Wootton, J. Claire Cameron, Andrew Smith, Paul Heath, Shamez Ladhani, Matthew D. Snape, Andrew J. Pollard, Richard Cunningham, Raymond Borrow, Caroline Trotter, Stephen J. Gray, Martin C. J. Maiden, Jenny M. MacLennan   +15 more
doaj   +1 more source

Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease

Canada Communicable Disease Report, 2020
Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison, Robert Stirling, Oliver Baclic, Wendy Vaudry   +3 more
doaj   +1 more source

Self Mutilating Behaviour in Severe Meningococcal Infection; An Interesting Association [PDF]

Journal of Clinical and Diagnostic Research, 2016
Neisseria meningitidis most commonly manifests as asymptomatic colonization in the nasopharynx of healthy adolescents and adults. It may rarely present as invasive disease which may be either bacterial meningitis or meningococcal septicaemia.
Anju Dinkar, Jitendra Singh, Virendra Atam, Krishna Kumar Sahani, Munna Lal Patel   +4 more
doaj   +1 more source

A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control

Microorganisms, 2021
Neisseria meningitidis, carried in the human nasopharynx asymptomatically by ~10% of the population, remains a leading cause of meningitis and rapidly fatal sepsis, usually in otherwise healthy individuals.
Yih-Ling Tzeng, David S. Stephens
doaj   +1 more source

Risk of Invasive Meningococcal Disease in Preterm Infants. [PDF]

Open Forum Infect Dis
Abstract Background Invasive meningococcal disease (IMD) is most common in the first year of life. We hypothesized that preterm infants may have a higher risk of IMD and more severe disease than term infants.
Calvert A, Campbell H, Heath PT, Jones CE, Le Doare K, Mensah A, Ladhani S.   +6 more
europepmc   +5 more sources

Current safety issues with quadrivalent meningococcal conjugate vaccines

Human Vaccines & Immunotherapeutics, 2018
Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae.
Tanya R. Myers, Michael M. McNeil
doaj   +1 more source

the course of a invasive meningococcal disease in a patient of military age from specific prophylaxis (clinical case)

Журнал инфектологии, 2020
Meningococcal infection is an acute infectious disease caused by Neisseria meningitidis, characterized by a polymorphism of clinical manifestations from meningococcus carriage to invasive forms.
V. V. Sharabkhanov, K. V. Zhdanov, S. M. Zakharenko, N. I. Lvov, K. V. Kozlov, E. N. Koudelka, Yu. I. Lyashenko, K. S. Ivanov, Yu. I. Bulankov, A. N. Kovalenko, M. V. Yaremenko, V. A. Cheprakova, N. A. Kuvshinova   +12 more
doaj   +1 more source

Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection

Canadian Journal of Infectious Diseases and Medical Microbiology, 2009
Canada is a leader in establishing routine infant immunization programs against meningococcal C disease. Currently, all provinces have routine programs to provide meningococcal C conjugate vaccines to infants and children.
Nicole Le Saux, Julie A Bettinger, Susan Wootton, Scott A Halperin, Wendy Vaudry, David W Scheifele, Raymond Tsang   +6 more
doaj   +1 more source